NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!

Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.

Start Free »

Zoetis Inc. ZTS | NYSE

$70.14 $0.31 | 0.44%

SIGNAL:

|2026-04-22 |F&G 25 |RSI 36.4

Add to favoritesFavorite

Company Overview:

Market Cap: $28.86B

Trailing PE: 11.6x

FWD PE *: 11.3x

Payout Ratio (TTM): 34.0%

52-Week Range: $69.52 - $148.79

* Forward PE is based on street estimates.

10 Year ZTS Performance Metrics:

Total Return (with DRIP): 46.1% (3.86% CAGR)

Total Return (no DRIP): 56.1% (4.55% CAGR)

Share Price: 34.9% (3.04% CAGR)

Yield on Cost (with DRIP): 4.42%

Total Invested: $10,000

Total Value (with DRIP): $14,609

Total Return $ (with DRIP): $4,609

Dividend Increase: 404.8% (18.14% CAGR)

Dividend Yield (FWD): 3.02% ($2.12)

ZTS 10-yr Total Return ($10K invested)

1M 3M 6M YTD 1Y 3Y 5Y 10Y

ZTS Share Price

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

ZTS Price CAGR:1Y: -52.27%2Y: -39.94%5Y: -18.59%10Y: 3.04%

ZTS Dividend Charts

ZTS - Dividends

ZTS Dividend CAGR:1Y: 6.00%2Y: 10.76%5Y: 16.22%10Y: 18.76%

ZTS - Dividend Payout Ratio

ZTS Dividend Payout Ratio CAGR:1Y: 3.91%2Y: 1.10%5Y: 6.78%10Y: 4.40%

ZTS - Dividend to Free Cash Flow Ratio

ZTS Dividend to FCF Ratio CAGR:1Y: -42.75%2Y: -11.77%5Y: 5.09%10Y: -3.07%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

ZTS Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

ZTS - Revenue

ZTS Revenue CAGR:1Y: 0.33%2Y: 2.24%5Y: 4.85%10Y: 7.41%

ZTS - Earnings Per Share (EPS)

ZTS EPS CAGR:1Y: 2.48%2Y: 9.74%5Y: 9.05%10Y: 13.87%

ZTS - Net Income

🔓 See the full chart40% off right now · 7-day free trial

ZTS Net Income CAGR:1Y: -3.76%2Y: 5.23%5Y: 6.18%10Y: 11.92%

ZTS - EBITDA

🔓 See the full chart40% off right now · 7-day free trial

ZTS EBITDA CAGR:1Y: 4.52%2Y: 4.68%5Y: 6.20%10Y: 11.71%

ZTS - Free Cash Flow

🔓 See the full chart40% off right now · 7-day free trial

ZTS Free Cash Flow CAGR:1Y: 74.68%2Y: 20.58%5Y: 7.89%10Y: 20.55%

ZTS - Free Cash Flow / Share

🔓 See the full chart40% off right now · 7-day free trial

ZTS Free Cash Flow / Share CAGR:1Y: 86.18%2Y: 25.94%5Y: 10.70%10Y: 22.65%

ZTS - Operating Income

🔓 See the full chart40% off right now · 7-day free trial

ZTS Operating Income CAGR:1Y: 1.01%2Y: 5.01%5Y: 6.65%10Y: 10.87%

ZTS - Gross Profit

🔓 See the full chart40% off right now · 7-day free trial

ZTS Gross Profit CAGR:1Y: 0.96%2Y: 4.05%5Y: 5.40%10Y: 8.30%

ZTS - Shares Outstanding

🔓 See the full chart40% off right now · 7-day free trial

ZTS Shares Outstanding CAGR:1Y: -6.24%2Y: -4.29%5Y: -2.62%10Y: -1.76%

ZTS - Share Buybacks

🔓 See the full chart40% off right now · 7-day free trial

ZTS Share Buybacks CAGR:1Y: 72.78%2Y: 4.67%5Y: 28.61%10Y: 22.78%

ZTS - Stock-Based Comp

🔓 See the full chart40% off right now · 7-day free trial

ZTS Stock-Based Comp CAGR:1Y: 18.18%2Y: 16.98%5Y: 10.20%10Y: 10.03%

ZTS - Expenses

🔓 See the full chart40% off right now · 7-day free trial

ZTS Expenses CAGR:1Y: -34.27%2Y: -5.85%5Y: 0.70%10Y: 8.04%

ZTS - Revenue vs Net Income

🔓 See the full chart40% off right now · 7-day free trial

ZTS - EPS vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

ZTS - EPS vs PE Ratio

🔓 See the full chart40% off right now · 7-day free trial

ZTS - FCF vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

ZTS - FCF vs Stock Based Comp

🔓 See the full chart40% off right now · 7-day free trial

ZTS - Cash & Debt

🔓 See the full chart40% off right now · 7-day free trial

ZTS - Revenue by Segment

🔓 See the full chart40% off right now · 7-day free trial

ZTS Revenue CAGR:1Y: 0.33%2Y: 2.24%5Y: 4.85%10Y: 7.41%

ZTS - Revenue by Region

🔓 See the full chart40% off right now · 7-day free trial

ZTS Revenue CAGR:1Y: 0.33%2Y: 2.24%5Y: 4.85%10Y: 7.41%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ZTS - REVENUE: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

ZTS Actual Revenue CAGR:1Y: 0.33%2Y: 2.24%5Y: 4.85%10Y: 7.41%

ZTS - EPS: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

ZTS Actual EPS CAGR:1Y: 2.48%2Y: 9.74%5Y: 9.05%10Y: 13.87%

ZTS - NET INCOME: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

ZTS Actual Net Income CAGR:1Y: -3.76%2Y: 5.23%5Y: 6.18%10Y: 11.92%

ZTS - EBITDA: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

ZTS Actual EBITDA CAGR:1Y: 4.52%2Y: 4.68%5Y: 6.20%10Y: 11.71%

Ratios, Profit Margins & Return on Capital:

ZTS - Net Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

ZTS Net Profit Margin CAGR:1Y: -4.08%2Y: 2.93%5Y: 1.28%10Y: 4.21%

ZTS - Gross Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

ZTS Gross Profit Margin CAGR:1Y: 0.62%2Y: 1.77%5Y: 0.53%10Y: 0.83%

ZTS - Price to Earnings

🔓 See the full chart40% off right now · 7-day free trial

ZTS Price to Earnings CAGR:1Y: -55.04%2Y: -41.20%5Y: -24.09%10Y: -8.44%

ZTS - Price To Sales Ratio

🔓 See the full chart40% off right now · 7-day free trial

ZTS Price To Sales Ratio CAGR:1Y: -56.91%2Y: -39.57%5Y: -23.17%10Y: -4.61%

ZTS - Return on Capital Employed

🔓 See the full chart40% off right now · 7-day free trial

ZTS Return on Capital Employed CAGR:1Y: -19.11%2Y: -0.87%5Y: 3.56%10Y: 2.74%

ZTS - Return on Invested Capital

🔓 See the full chart40% off right now · 7-day free trial

ZTS Return on Invested Capital CAGR:1Y: -9.07%2Y: -1.00%5Y: 2.92%10Y: 3.37%

ZTS Dividends Info:

Annual Dividend: $2.12

Forward Yield: 3.02%

Ex-Dividend Date: 2026-07-20

Lifetime Dividends / Share: $12.69

ZTS Dividend History: Dates, Payments & Yield list

Below is a schedule of all ZTS dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date	Payment Date	Amount	Yield	Forward Yield	Price on Ex-Date
07/20/2026	07/22/2026	$0.530	2.78%	2.86%	$74.19
04/20/2026	04/22/2026	$0.530	1.73%	1.8%	$117.52
01/20/2026	01/22/2026	$0.530	1.72%	1.7%	$124.40
10/31/2025	11/03/2025	$0.500	1.39%	1.39%	$144.35
07/18/2025	07/21/2025	$0.500	1.35%	1.36%	$147.37
04/21/2025	04/23/2025	$0.500	1.36%	1.33%	$150.91
01/21/2025	01/23/2025	$0.500	1.19%	1.2%	$166.96
10/31/2024	11/04/2024	$0.432	0.97%	0.99%	$175.18
07/18/2024	07/22/2024	$0.432	0.96%	0.96%	$180.76
04/18/2024	04/22/2024	$0.432	1.13%	1.19%	$145.54
01/18/2024	01/22/2024	$0.432	0.91%	0.9%	$191.20
10/31/2023	11/02/2023	$0.375	0.96%	0.93%	$160.91
07/20/2023	07/24/2023	$0.375	0.87%	0.81%	$185.58
04/20/2023	04/24/2023	$0.375	0.86%	0.85%	$176.35
01/19/2023	01/23/2023	$0.375	0.93%	0.9%	$166.75
10/31/2022	12/01/2022	$0.325	0.86%	0.83%	$156.64
07/20/2022	09/01/2022	$0.325	0.74%	0.82%	$159.41
04/20/2022	06/01/2022	$0.325	0.69%	0.78%	$167.02
01/19/2022	03/01/2022	$0.325	0.65%	0.68%	$192.54
10/28/2021	12/01/2021	$0.250	0.47%	0.46%	$219.66
07/20/2021	09/01/2021	$0.250	0.5%	0.48%	$206.44
04/20/2021	06/01/2021	$0.250	0.59%	0.57%	$174.19
01/19/2021	03/01/2021	$0.250	0.62%	0.63%	$157.69
10/20/2020	12/01/2020	$0.200	0.5%	0.5%	$161.36
07/16/2020	09/01/2020	$0.200	0.56%	0.49%	$162.05
04/16/2020	06/01/2020	$0.200	0.63%	0.58%	$138.34
01/16/2020	03/03/2020	$0.200	0.57%	0.58%	$137.24
10/21/2019	12/02/2019	$0.164	0.52%	0.55%	$119.91
07/18/2019	09/03/2019	$0.164	0.57%	0.52%	$127.04
04/17/2019	06/03/2019	$0.164	0.67%	0.63%	$103.95
01/17/2019	03/01/2019	$0.164	0.78%	0.69%	$95.75
11/19/2018	12/03/2018	$0.126	0.56%	0.54%	$93.57
07/19/2018	09/04/2018	$0.126	0.59%	0.56%	$89.97
04/19/2018	06/01/2018	$0.126	0.59%	0.59%	$85.42
01/18/2018	03/01/2018	$0.126	0.66%	0.63%	$80.44
11/08/2017	12/01/2017	$0.105	0.6%	0.58%	$72.30
06/13/2017	09/01/2017	$0.105	0.68%	0.67%	$62.87
04/04/2017	06/01/2017	$0.105	0.8%	0.67%	$62.64
01/18/2017	03/01/2017	$0.105	0.79%	0.78%	$53.89
11/01/2016	12/01/2016	$0.095	0.8%	0.77%	$49.16
06/28/2016	08/30/2016	$0.095	0.82%	0.75%	$50.75
04/05/2016	06/01/2016	$0.095	0.83%	0.79%	$47.85
01/19/2016	03/01/2016	$0.095	0.88%	0.9%	$42.10
11/03/2015	12/01/2015	$0.083	0.71%	0.71%	$47.01
08/11/2015	09/01/2015	$0.083	0.69%	0.75%	$43.98
04/07/2015	06/02/2015	$0.083	0.72%	0.67%	$49.58
01/20/2015	03/03/2015	$0.083	0.76%	0.71%	$46.54
11/03/2014	12/02/2014	$0.072	0.76%	0.64%	$44.74
08/18/2014	09/02/2014	$0.072	0.85%	0.81%	$35.48
04/24/2014	06/02/2014	$0.072	0.96%	0.93%	$30.92
01/28/2014	03/04/2014	$0.072	0.92%	0.93%	$30.89
10/30/2013	12/02/2013	$0.065	0.81%	0.83%	$31.15
07/30/2013	09/02/2013	$0.065	0.87%	0.88%	$29.43
04/29/2013	06/06/2013	$0.065	0.8%	0.81%	$32.08

Projected Future Returns & Dividends for ZTS

Based on past 10-year performance, here are ZTS growth metrics:

Share price CAGR of +3.04%
Dividend CAGR of +18.98%

Using ZTS CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	ZTS (DRIP)	ZTS - No DRIP
Current Price	$70.14	$70.14
Start Shares	142.57	142.57
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	265.67	142.57
Dividends Payment	$3.01	$3.01
Annual Dividends	$3,202	$1,718
Yield on cost	32.02%	17.18%
Share Price	$94.59	$94.59
Total Dividends	$10,396	$7,461
Final Value	$25,129	$20,947

Estimated Future Value + Dividends - ZTS

NOTE: Above numbers are our estimate based on ZTS's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Zoetis Inc. (ZTS) had its IPO on 2013-02-01, and is traded on NYSE stock exchange.

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.

ZTS website: https://www.zoetis.com

Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

DCF Model — ZTS

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $70.14

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →